Dr. Carla Cohen,
Ph.D.
Postdoctoral Fellow
Department: Terry Fox Laboratory
Contact
Information:
Tel: 604-675-8000 Ext. 7770
Fax: 604-877-0712
Email: ccohen@bccrc.ca
Research Interest:
ERVs as
alternative promoters in human placenta
The genomic structure
of endogenous retroviruses (ERVs) consists of protein coding genes
flanked by Long Terminal Repeats (LTRs).
LTRs include promoter elements that initiate transcription of ERV
genes, and in some cases LTRs have also been shown to act as alternative
promoters for nearby cellular genes.
According to the LTR sequence the tissue specificity of
expression may be affected, and there are several cases in the
literature in which the presence of the LTR confers specific expression
in placenta. I am currently
investigating the regulatory mechanisms that underlie this specificity
through identification of common transcription factor binding sites.
Determining whether these regulatory sites were present in the
original ERV insertion or have subsequently been acquired by mutation
will help us understand the evolutionary basis of this phenomenon.
Thanks to Dr Wendy Robinson at the Child & Family Research Institute,
Vancouver,
BC
for providing placental samples.
Bioinformatics analysis
performed by David Arenillas and Dr Wyeth Wasserman at the Centre for
Molecular Medicine and Therapeutics, Vancouver, BC.
Epigenetic
regulation of cytokine genes in human Th17 cells
The
traditional view of T cell differentiation into Th1 and Th2 cells has
been upset by the discovery of regulatory T cells (Treg), and more
recently of Th17 cells. Th17
cells are required for immunity against a number of extracellular
bacterial pathogens but are also involved in autoimmune diseases such as
inflammatory bowel disease and psoriasis.
They have been shown to have a distinct cytokine profile
including IL-17, IL-22, and IL-21, and their differentiation involves
activation of the transcription factor RORγt through the STAT3 pathway.
In the Th1/Th2 system it has been shown that epigenetic
mechanisms govern the regulation of key cytokine genes such as
IFNG and
IL4.
I aim to continue preliminary findings in murine models that
suggest this may be the case in Th17 cells, and use these tools to
understand the developmental plasticity between human Th1, Th17 and Treg.
This
project is in collaboration with Sarah Crome and Megan Levings at the
Jack Bell Research Centre,
Vancouver,
BC.
Degrees:
MA
(Cantab), Natural Sciences,
University
of
Cambridge
(Selwyn
College),
2002
DPhil,
Dunn
School of
Pathology,
University
of
Oxford,
2006
Hobbies:
I’m
a member of the Vancouver Cantata Singers and I enjoy skiing.
|